AAAAAA
Results:
1-13
|
Results: 13
Authors:
Fukuhara, M
Neves, LA
Li, P
Diz, DI
Ferrario, CM
Brosnihan, KB
Citation: M. Fukuhara et al., The angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in the rat hind-limb vascular bed in vivo, J HYPERTENS, 19(3), 2001, pp. 561-566
Authors:
Ueda, S
Masumori-Maemoto, S
Wada, A
Ishii, M
Brosnihan, KB
Umemura, S
Citation: S. Ueda et al., Angiotensin(1-7) potentiates bradykinin-induced vasodilatation in man, J HYPERTENS, 19(11), 2001, pp. 2001-2009
Authors:
Herrington, DM
Brosnihan, KB
Pusser, BE
Seely, EW
Ridker, PM
Rifai, N
MacLean, DB
Citation: Dm. Herrington et al., Differential effects of E and droloxifene on C-reactive protein and other markers of inflammation in healthy postmenopausal women, J CLIN END, 86(9), 2001, pp. 4216-4222
Authors:
Herrington, DM
Pusser, BE
Riley, WA
Thuren, TY
Brosnihan, KB
Brinton, EA
MacLean, DB
Citation: Dm. Herrington et al., Cardiovascular effects of droloxifene, a new selective estrogen receptor modulator, in healthy postmenopausal women, ART THROM V, 20(6), 2000, pp. 1606-1612
Authors:
Herrington, DM
Reboussin, DM
Brosnihan, KB
Sharp, PC
Shumaker, SA
Snyder, TE
Furberg, CD
Kowalchuk, GJ
Stuckey, TD
Rogers, WJ
Givens, DH
Waters, D
Citation: Dm. Herrington et al., Effects of estrogen replacement on the progression of coronary-artery atherosclerosis, N ENG J MED, 343(8), 2000, pp. 522-529
Authors:
Li, P
Fukuhara, M
Diz, DI
Ferrario, CM
Brosnihan, KB
Citation: P. Li et al., Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-Induced vasoconstriction in canine coronary arteries and human platelet aggregation, J PHARM EXP, 292(1), 2000, pp. 238-246
Authors:
Levy, PJ
Yunis, C
Owen, J
Brosnihan, KB
Smith, R
Ferrario, CM
Citation: Pj. Levy et al., Inhibition of platelet aggregability by losartan in essential hypertension, AM J CARD, 86(11), 2000, pp. 1188-1192
Authors:
Gallagher, PE
Li, P
Lenhart, JR
Chappell, MC
Brosnihan, KB
Citation: Pe. Gallagher et al., Estrogen regulation of angiotensin-converting enzyme mRNA, HYPERTENSIO, 33(1), 1999, pp. 323-328
Authors:
Yamada, K
Iyer, SN
Chappell, MC
Brosnihan, KB
Fukuhara, M
Ferrario, CM
Citation: K. Yamada et al., Differential response of angiotensin peptides in the urine of hypertensiveanimals, REGUL PEPT, 80(1-2), 1999, pp. 57-66
Authors:
Brosnihan, KB
Senanayake, PS
Li, P
Ferrario, CM
Citation: Kb. Brosnihan et al., Bi-directional actions of estrogen on the renin-angiotensin system, BRAZ J MED, 32(4), 1999, pp. 373-381
Authors:
Senanayake, PD
Smeby, RR
Martins, AS
Moriguchi, A
Kumagai, H
Ganten, D
Brosnihan, KB
Citation: Pd. Senanayake et al., Adrenal, kidney, and heart angiotensins in female murine Ren-2 transfectedhypertensive rats, PEPTIDES, 19(10), 1998, pp. 1685-1694
Authors:
Brosnihan, KB
Citation: Kb. Brosnihan, Effect of the angiotensin-(1-7) peptide on nitric oxide release, AM J CARD, 82(10A), 1998, pp. 17S-19S
Authors:
Brosnihan, KB
Citation: Kb. Brosnihan, Effect of the angiotensin-(1-7) peptide on nitric oxide release - Questions and answers, AM J CARD, 82(10A), 1998, pp. 19S-19S
Risultati:
1-13
|